Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn’s disease patients with perianal lesions: a systematic review
- Resource Type
- Authors
- Marco Pozzi; Faizan Mazhar; Emilio Clementi; Sonia Radice; Vera Battini; Giulia Mosini; Piergiorgio Danelli; Gloria Zaffaroni; Anna Maffioli; Carla Carnovale
- Source
- Expert Opinion on Biological Therapy. 20:239-251
- Subject
- musculoskeletal diseases
0301 basic medicine
medicine.medical_specialty
Necrosis
viruses
Clinical Biochemistry
Tumour necrosis factor alpha
Gastroenterology
03 medical and health sciences
0302 clinical medicine
Crohn Disease
Internal medicine
Outcome Assessment, Health Care
Drug Discovery
medicine
Adalimumab
Humans
skin and connective tissue diseases
Pharmacology
Clinical Trials as Topic
Crohn's disease
Tumor Necrosis Factor-alpha
business.industry
Anemia
medicine.disease
Infliximab
Treatment Outcome
030104 developmental biology
030220 oncology & carcinogenesis
Disease remission
Tumor necrosis factor alpha
medicine.symptom
business
medicine.drug
- Language
- ISSN
- 1744-7682
1471-2598
Introduction: Anti-Tumor Necrosis Factor-alpha (TNF-α) therapy, primarily infliximab and adalimumab, are now increasingly used to induce and maintain disease remission in the pediatric perianal Cro...